IMCR
Immunocore Holdings Ltd
30.30$
-1.8%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
Immunocore Holdings Ltd (IMCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -8.0 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40 | -18 | -37 | -62 | -17 | -101 | -61 | -143 | -49 | 2.3 | 26 | -8.0 | |
| 0.7 | 1.4 | 2.8 | 4.2 | 6.7 | 9.2 | 9.0 | 7.6 | 5.3 | 3.2 | 4.2 | 2.4 | |
| 0.1 | 1.5 | 1.7 | 3.3 | 0.7 | 3.1 | 8.2 | 49 | 33 | 26 | 34 | 38 | |
| – | – | -2.2 | -5.7 | -19 | 3.4 | 33 | 45 | 22 | – | – | – | |
| -1.2 | -1.7 | -3.5 | -17 | 68 | -10 | -29 | -22 | -24 | 4.6 | 45 | -6.9 | |
| 2.0 | 5.8 | 6.2 | 18 | 3.5 | 4.3 | 3.1 | 1.4 | 2.2 | 4.3 | 5.2 | 3.2 | |
| -5.7 | -5.2 | 29 | -9.7 | 58 | -4.1 | 0.5 | -1.3 | -2.2 | -4.3 | -355 | -12 | |
| – | – | – | – | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | – | – | |
| – | – | 19 | 19 | -4.0 | -4.0 | 33 | -3.2 | -3.2 | 0.0 | 353 | 0.0 | |
| 0.4 | 158 | 0.1 | 19 | 0.1 | 55 | 116 | 288 | 145 | 27 | 344 | 9.2 | |
| 51 | – | 134 | -52 | 42 | -50 | 56 | 144 | 81 | 32 | 13 | 8.9 | |
| 38 | -24 | -43 | -79 | -20 | -106 | -64 | -144 | -51 | -2.0 | 21 | -11 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.